最高のウイルス性肝炎医師 - トップ19名の医師

Assoc. Prof. Dr. Ramazan GÖZÜKÜÇÜK was born in 1973. He graduated from Çukurova University, Faculty of Medicine in 1996.

He completed his residency training at Ankara Numune Training and Research Hospital in 2001.

He obtained his Competency Certificates in Infectious Diseases and Clinical Microbiology in 2009 and 2012.

He has participated in 22 congresses domestically and 15 congresses internationally, with 15 published papers.

MEDICAL INTERESTS

• Hospital infections,
• Viral hepatitis,
• Sterilization and disinfection
• Medical genetics and molecular biology.
• Emerging and re-emerging infections.
• Vaccines and travel infections.

医学的関心分野

• 高血圧
• 高脂血症
• 甲状腺疾患
• 糖尿病および血管の問題
• 慢性疾患のフォローアップ
• 病因学 - 診断研究

教育:

学士: イスタンブール大学イスタンブール医学部

専門: イスタンブール大学イスタンブール医学部

修士: オカン大学健康管理学

訓練および勤務機関

ヒサールインターコンチネンタル病院

コズヤタギ中央病院

トルコ新聞病院

ヤシャル病院

メディカルメディスンセンター

カスンパサ軍病院

バイラムパシャ州立病院

イスタンブール医学部

バルティン、エリバシュ健康センター

Dr. Süveyda Gözüküçük completed her medical education at Çukurova University Faculty of Medicine. She then specialized in Infectious Diseases at Erciyes University Faculty of Medicine and is currently serving her patients in the Infectious Diseases department at Hisar Hospital Intercontinental. Her medical interests include Infection Management in Special Convalescence (Immunocompromised), Hospital Infections, and Sterilization and Disinfection.

MEDICAL INTERESTS

• Hospital Infections
• Sterilization and Disinfection
• Hepatitis

シボレト博士は、50年以上の実践経験を持つイスラエルのトップの消化器病専門医であり、血液学者です。彼はイヒロヴ医療センターのデータによれば、イスラエルの肝臓の専門家として知られています。

専門分野

オレン・シボレト博士の主な専門分野は肝疾患の治療です。彼は、慢性肝炎や自己免疫、遺伝性肝疾患のような重篤な場合でも、肝臓のあらゆる病理の治療と診断を提供しています。

職務経歴

• スルアスキ（イヒロヴ）医療センターの肝臓科の責任者。

学歴

• ヘブライ大学医学部 — 一般医学の学位
• ヘブライ大学ハダッサ医科大学校 — 消化器学の専門。

科学活動

シボレト博士は肝疾患の研究を行っており、60を超える出版物と100の会議要旨の著者です。

組織への所属

• イスラエル消化器病学会
• アメリカ消化器学会
• ヨーロッパ肝臓研究会議
• アメリカ肝疾患学会。

ガリア・グリサル＝ソエン博士は、小児感染症に特化した経験豊富で知識豊富な医師であり、ダナ＝ドウェク小児病院の小児感染症サービスのディレクターです。彼はマルゼ・バヒルの学位を持ち、サフラ子供病院およびトロント大学での経験があります。主なポイントには以下が含まれます：

• 小児感染症の専門
• ダナ＝ドウェク小児病院における小児感染症サービスのディレクター
• マルゼ・バヒルの学位
• サフラ子供病院およびトロント大学での経験

ラファエル・ブルック教授は、イスラエルでトップクラスの消化器内科医の一人であり、40年以上の臨床経験を持っています。

専門

ラファエル・ブルック教授の専門は、食道、胃、小腸および大腸、膵臓、消化器系の癌の急性および慢性疾患の治療です。

ブルック教授は肝臓学の専門家であり、胆管および肝臓の異常、代謝障害のある患者を治療しています。ラファエル・ブルック医師は、B型およびC型肝炎ウイルスの症状を排除するための最新の医療スキームを適用しています。

職歴

• ソウラスキー医療センターの主任消化器内科医
• ウルフソン医療センターの消化器内科医。

学歴

• テルアビブ大学の医学部。

所属団体

• イスラエル医師会
• イスラエル消化器・肝臓病学会
• アメリカ医師会。

EDUCATION

• Graduated in General Medicine at Universidad Autónoma de Nayarit in Mexico
•  
• Training in Forensic Medicine at Jalisco Institute of Forensic Sciences in Mexico
•  
• Training in Regenerative Geriatric Medicine at Nordic University
•  
• Master’s Degree in Regenerative Medicine at Universidad Catolica de Murcia in Madrid, Spain
•  
• Training in Regenerative Medicine at Nordic University

EXPERIENCE

• Founder of the biotechnological institute “Bioplenum S.A de C.V”
•  
• Collaborated in clinical protocols in Lyon, France, with Dr. Lourdes Sagnard
•  
• Clinical researcher in many protocols involving mesenchymal stem cells to treat autoimmune and chronic degenerative diseases, including: diabetes, asthma, ischemic events, ALS (Lou Gehrig’s disease), arthritis, kidney failure, lupus, aesthetic facial regeneration, and as an anti-inflammatory and immunomodulatory agent

ACCOLADES

• HemoFenix France representative in Mexico and Latin America
•  
• Kimicor Pharma representative at the Italian laboratory in Mexico
•  
• Krebs International, General Director for the company located in Bulgaria
•  
• General Director for Immunotherapy for México A.C. foundation

ジークベルト・ロッソル博士：34年以上の医学的消化器病理学の専門知識

• ドイツ消化器代謝病学会の会員
• ヨーロッパ消化器委員会、ドイツ肝研究協会（GASL）、欧州肝研究協会（EASL）、米国肝疾患研究協会（AASLD）、ドイツ健康経済学会eV（dggö）の会員
• 1980年から1986年までハンブルク、マールブルク、ギーセンで医学を学び、アレクサンダー・フォン・フンボルト奨学金を受け入れた
• 肝研究所、R. ウィリアムズ教授、キングスカレッジスクール、ロンドン大学、1995年
• 1999年にマンハイム大学とハイデルベルク大学の健康管理アカデミーで高等教育を学び、理学修士号（M.Sc.）を取得
• 介入的超音波検査、ゼンカー憩室の内視鏡治療、腸癌（EMR/ESD）の内視鏡的切除、エンドバリア、IBD（炎症性腸疾患）の治療における卓越した専門知識
• 国内外の様々な学術誌に発表された記事と出版物
• 1986年卒業、ハンブルク大学、マールブルク大学、ギーセン大学

ヴィクトル・アレクサンダー・クロール博士は、デュッセルドルフのザンクト・マルティヌス病院の消化器内科部長を務め、肝臓および消化器疾患を専門としています。

• 消化器内科・内科部長
• 認定肥満治療センター長
• 高度な内視鏡検査および診断技術を使用
• 肝疾患に対する包括的な治療を提供

Professor Huang Wenqi is a hepatologist with over 30 years of experience. He focuses on clinical cure and antiviral therapy for chronic hepatitis B, and on the management of liver cirrhosis. He uses an integrated approach combining Traditional Chinese and Western medicine. He provides artificial liver support, including plasma exchange and dual bilirubin adsorption. He also offers minimally invasive diagnosis and treatment, liver fibrosis assessment, and differential diagnosis for jaundice and unexplained liver function impairment.

National Committee Member of the National Collaborative Group for Refractory and Severe Liver Diseases. Executive Committee member of the China Liver Failure Blood Purification (Yuanhang) Project. Council Director of the Specialized Alliance of Liver and Infectious Diseases at You’an Hospital, Capital Medical University. National consulting expert in liver diseases.

Experience

2017 - 2020 Acıpayam State Hospital

2016 - 2017 Izmir Public Health Laboratory

2013 - 2016 Bozyaka Training and Research Hospital

2011 - 2013 Pendik State Hospital

2011 - 2011 Midyat State Hospital

2004 - 2010 Dokuz Eylul University Faculty of Medicine

Acipayam State Hospital

Izmir Public Health Laboratory

Bozyaka Training and Research Hospital

Pendik State Hospital

Midyat State Hospital

Dokuz Eylul University Faculty of Medicine

Education

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2010 Dokuz Eylul University Faculty of Medicine, Infectious Diseases and Clinical Microbiology

2004 Ege University, Faculty of Medicine

2004 Ege University, Faculty of Medicine

Publications

ARTICLES PUBLISHED IN INTERNATIONAL REFEREED JOURNALS

Bulent Ertugrul, Çağrı Buke, Özlem Saylak Ersoy, Bengisu Ay, Dilek Senen Demirez, Öner Savk. Intralesional epidermal growth factor for diabetic foot wounds: the first cases in Turkey. Diabetic foot and ankle.6: August 2015

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Causative pathogens and antibiotic resistance in diabetic foot infections: A prospective multi-center study. Journal of Diabetes and its Complications, Volume 30, Issue 5, July 2016,910-916

Alpay Arı, Ali Ilgın Olut, Bengisu Ay, Selma Tosun, Meltem Zencir, Mehmet Umut Çayıröz. A small outbreak of Serratia liquefaciens bacteremia due to use of contaminated saline infusion solution for myocardial perfusion scintigraphy. Journal of Infectious Diseases, Volume 49, 2017, 639-40

B- PAPERS PRESENTED IN INTERNATIONAL SCIENTIFIC CONFERENCES AND PUBLISHED IN PROCEEDINGS

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Bacterial Etiology And Antimicrobial Resistance In Dfıs; A Multicenter Prospective Trial Of “Turk-Day”. Congress of Balkan Millitary Medical Committee, 8-11 June 2015, Greece

C- ARTICLES PUBLISHED IN NATIONAL REFEREED JOURNALS

VildanAvkan Oğuz, Bengisu Ay, Vasfi Karatosun, Zeynep Gülay; A Case of Total Knee Arthroplasty in which Aeromonas Hydrophila Was Isolated in Perioperative Culture: Trakya Univ Medical Faculty Journal, 2009

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group recommended for influenza vaccination. Medical Journal of İzmir Hospital 2013; 17 (4): 241-245

B Ay, S Calik, B Karaca, S Tosun. Atypical Mediterranean spotted fever: First case from Aegean Region. Izmir Tepecik Education and Research Hospital Journal. 2016; 26(2):175-177

B Ay, E Ozdemir, N Unel, S Calik, B Karaca. Telbivudine-Related Myopathy: A Case Report. Viral Hepat J 2016; 22: 37-38

D- PAPERS PRESENTED IN NATIONAL SCIENTIFIC MEETINGS AND PUBLISHED IN PROCEEDINGS

Şebnem Çalık, Bengisu Kara Ay, Arif Yüksel, Kamuran Çapcıoğlu, Meltem Zencir, Ümran Bingöl, Neslihan Genç, Meltem Avcı, Selma Tosun. Evaluation of the knowledge level and vaccination status of individuals in the risk group who are recommended to receive influenza vaccination. 5th National Vaccine Symposium, 25-29 September 2013, Ankara

''Evaluation of 4 Patients Receiving Telaprevir for Chronic Hepatitis C'' “Speech 7" Istanbul – Marriott Asia Hotel; 'Our Turkey Teleprevir Experience Symposium, 21 September 2013'

Bengisu Ay, Alpay Arı, Nalan Ünel, Erman Özdemir, Selma Tosun; Our experience with telaprevir in two centers: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Bengisu Ay, Erman Özdemir, Nalan Ünel; Myopathy side effect of telbivudine treatment due to a case: 12th National Viral Hepatitis Congress, 26-29 March 2014, Belek/Antalya

Gülsüm Altın, Aslı Keleş, Bengisu Ay, Ebru Dik, Meltem Zencir, Halil Erkan, Selma Tosun. Evaluation of the differences and knowledge levels of individuals in the society about the transmission routes of Hepatitis B virus. BUHASDER 6. Tepecik Infection Days Symposium. 04-08 November 2015 Muğla.

Vedat Turhan, Günalp Uzun, Mustafa Hatipoglu, Mesut Mutluoglu, Erol Sevim, Hayati Demiraslan, Esma Eryılmaz, Cem Ozuguz, Ali Memis, Turk-Day Working Group (Hakan Ay, Bilgin Arda, Serhat Uysal, Vicdan Koksaldi Motor, Cigdem Kader, Ayse Erturk, Omer Coskun, Fazilet Duygu, Selma Guler F. Aybala Altay, Aziz Ogutlu, Sibel Bolukcu, Ozlem Kandemir, Halide Aslaner, Arife Polat, Mustafa Karahocagil, Kadriye Kart Yasar, Emine Sehmen, Sirri Kilic, Mustafa Sunbul, Serap Gencer, Fatma Bozkurt, Tugba Yanik, Nefise Oztoprak Cuvalci, Ayse Batirel, Hamdi Sozen, Inci Kilic, Ilhami Celik, Bengisu Ay, Selma Tosun, Ayten Kadanali, Senol Comoglu, Affan Denk, Salih Hoşoğlu, Özlem Aydın, Nazif Elaldı, Şerife Akalın, Bahar Kandemir, Ayhan Akbulut, Tuna Demirdal, Recep Balık, Emel Azak, Gönül Şengöz); Current Causative Microorganisms and Antimicrobial Susceptibilities in Diabetic Foot Infection; A Multicenter Study “TURK-DAY”. 5th EKMUD Scientific Platform, 01-04 April 2015, İzmir.

Dr. Antonia Artigues-Barcelo is an experienced Internal Medicine Consultant with over 20 years in the field. She earned her medical degree from Universitat Autònoma de Barcelona. She completed her Internal Medicine training at Hospital Universitario Son Dureta. She also specialized in Autoimmune Systemic Diseases at Hospital Clinic de Barcelona in 1998.

Dr. Artigues-Barcelo is registered with the GMC in Spain. She works as an Adjunct Clinical Associate Professor of Internal Medicine at MBRU Dubai. She has helped develop specialized units for Autoimmune Systemic Diseases and Palliative Care. She also has expertise in infectious diseases and antimicrobial treatment, certified by Cardinal Herrera University CEU.

Prof. Dr. Ali İnal is a physician with over 25 years of experience. He specializes in Clinical Microbiology, Infectious Diseases, Immunology, and Allergy. He works as a Professor in the Department of Immunology and Allergy at Başkent University Istanbul Hospital.

Dr. İnal completed his training in Clinical Microbiology and Infectious Diseases. He also finished a fellowship in Clinical Immunology and Allergy. He has managed Immunology and Tissue Typing Laboratories for more than 20 years. He has played a key role in improving transplant immunology and diagnostic immunology services.

His research covers cytokine storms in COVID-19, donor-specific antibodies, transplant rejection, autoimmunity, and primary immunodeficiencies. Dr. İnal has published many scientific articles. He has received research awards and grants. He also takes part in national and international congresses.

Education

• Undergraduate: Ankara University 1997-2003
• Residency: Ankara Dr. Sami Ulus Children's Hospital Pediatrics 2003-2009
• Subspecialization: Marmara University Faculty of Medicine Pediatric Infectious Diseases 2009-2013

Experience

• Interuniversity Council 2017
• Marmara University Faculty of Medicine 2018-2019
• Marmara University Faculty of Medicine 2019-2023
• Bahcesehir University Faculty of Medicine 2024
• Biruni University Faculty of Medicine 2024- present

He graduated from Ankara University Faculty of Medicine in 2003, completed his specialization in Pediatrics at Ankara Dr. Sami Ulus Children's Hospital in 2009, and completed his subspecialization in Pediatric Infectious Diseases at Marmara University Faculty of Medicine, Department of Pediatric Infectious Diseases in 2013. He has contributed to the education of many medical students, pediatric residents and subspecialty residents within Marmara University Faculty of Medicine. He trained 8 pediatric infectious diseases subspecialists between 2018 and 2023 as the Head of the Department. Tuberculosis disease, HIV infection, prevention and treatment of infections in children with immune defects, healthcare-associated infections, vaccine-preventable diseases in children, Covid-19 Pandemic management.He has participated as a member of many commissions, as a researcher in projects and as an author in consensus guidelines and has provided patient care services on these issues in the clinics where he works.In our country, he prepares 'Rational Antibiotic Use' training materials and provides training to family physicians and pediatricians on this subject.

Medical Intrests

• 
  Fire
• Vaccines
• Upper and lower respiratory tract infections
• Child with diarrhoea
• Rash diseases
• Tuberculosis
• Skin and soft tissue infections
• HIV infection

The doctor analyzes the patient's health condition, taking into account his physical, social and psychological characteristics. Selects the optimal treatment and monitors its implementation, and also ensures long-term monitoring of the patient's health. Organizes consultations with specialized specialists, refers for laboratory tests and diagnostic procedures, conducts preventive and explanatory work with the patient and his family.

The doctor treats such diseases as anaphylactic shock, arterial hypertension, ischemic heart disease, angina pectoris, chronic obstructive pulmonary disease. Also treats cystitis, gastritis and acute respiratory viral infection.

Dr. Julio Valle Muñoz has a degree in medicine and surgery, and is a specialist in the digestive system. Associate Physician of the Digestive System Service of the Virgen de la Salud Hospital in Toledo. In addition, he has worked for several years as an Assistant Professor of Medicine at the University Hospital of Helsinki (Finland), where he obtained the degree of Doctor of Medicine.

Head of the Gastroenterology and Hepatology Department, Gastroenterologist